An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

Clinical trial NCT01585987 · COMPLETED

Trial details

NCT number

NCT01585987

Sponsor

Bristol-Myers Squibb

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2012-07-01

Primary completion

2014-07-01

Enrollment

143

View on ClinicalTrials.gov